Lonza readies as pharma sector boosts Singapore production

A pharma production boost offset slumping electronics manufacturing, giving Singapore its biggest industrial production surge in 5 months. Pharmaceutical output soared 157%, while electronics production declined 22% compared with a year earlier.

For Singapore, it translates into a 22% industrial production increase over a year ago, according to its Economic Development Board, as reported by Bloomberg.

Manufacturing accounts for more than 20% of Singapore's economy, the report says. The question for economists is whether the August performance is a fluke, the start of a trend, or something else.

Contract manufacturer Lonza, for one, appears to see plenty of potential there. In the last few months, the CMO has announced a $12 million plan to expand its biopharmaceutical development services platform in Singapore and plans a secondary listing on the Singapore Stock Exchange.

- here's the story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.